We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Age of Transfused Blood in Critically Ill Adults Assessed

By LabMedica International staff writers
Posted on 06 Apr 2015
Print article
Image: Plastic bag of red blood cells tested and typed as O Rh positive, ready for transfusion (Photo courtesy of the American Red Cross).
Image: Plastic bag of red blood cells tested and typed as O Rh positive, ready for transfusion (Photo courtesy of the American Red Cross).
Blood for transfusion that has been stored for three weeks appears to be just as good as fresh blood for critically ill patients in need of red blood cell transfusion.

Current regulations permit the storage of red cells for up to 42 days, but prolonged storage has been associated with changes that may render red cells ineffective as oxygen carriers and that lead to the accumulation of substances that have untoward biologic effects.

An international team of scientists led by those at Sainte-Justine University Hospital (Montreal, QC, Canada) enrolled critically ill adults from tertiary care intensive care units (ICUs) at 64 centers; 26 in Canada, 20 in the United Kingdom, 10 in France, 7 in the Netherlands, and 1 in Belgium. Between March 2009 and May 2014, at the various centers, 1,211 patients were assigned to receive fresh red cells (fresh-blood group) and 1,219 patients were assigned to receive standard-issue red cells.

Red cells were stored a mean (± standard deviation) of 6.1 ± 4.9 days in the fresh-blood group as compared with 22.0 ± 8.4 days in the standard-blood group. At 90 days, 448 patients (37.0%) in the fresh-blood group and 430 patients (35.3%) in the standard-blood group had died. There were no significant between-group differences in any of the secondary outcomes such as major illnesses; duration of respiratory, hemodynamic, or renal support; length of stay in the hospital; and transfusion reactions or in the subgroup analyses.

The authors concluded that transfusion of fresh red cells, as compared with standard-issue red cells, did not decrease the 90-day mortality among critically ill adults. Blood transfusions save lives, but there is no need to worry about the safety of the age of blood routinely used in hospitals. Alan Tinmouth, MD, a physician and scientist and a coauthor of the study said, “Previous observational and laboratory studies have suggested that fresh blood may be better because of the breakdown of red blood cells and accumulation of toxins during storage. But this definitive clinical trial clearly shows that these changes do not affect the quality of blood.” The study was published on March 17, 2015, in the New England Journal of Medicine (NEJM).

Related Links:
Sainte-Justine University Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.